CAR Therapy Beyond T-Cells: CAR-NK Cells or Even CAR In Stem Cells for Cancer Immunotherapy?
Time: 10:30 am
day: Focus Day - Track B - Morning
Details:
- CAR-T cells have a limited efficacy in solid tumours
- CAR-NK cells may become the best strategy for off-the-shelf solid tumour CAR-therapy
- CAR in Hematopoietic stem cells (CAR-HSC) may also be an alternative strategy that would combine both CAR-T and CAR-NK cells
